Results 31 to 40 of about 19,264 (196)

Deficiency in type 1 insulin-like growth factor receptor in mice protects against oxygen-induced lung injury

open access: yesRespiratory Research, 2005
Background Cellular responses to aging and oxidative stress are regulated by type 1 insulin-like growth factor receptor (IGF-1R). Oxidant injury, which is implicated in the pathophysiology of a number of respiratory diseases, acutely upregulates IGF-1R ...
Flejou Jean-François   +7 more
doaj   +1 more source

The Role of IGF-1R in Pediatric Malignancies [PDF]

open access: yesThe Oncologist, 2009
Learning Objectives Evaluate the components that make up the insulin-like growth factor family. Differentiate between different strategies to modulate IGF-1R. Determine when to utilize the rationale for therapeutic targeting of IGF-1R in childhood malignancies.
Su Young, Kim   +3 more
openaire   +2 more sources

GIGYF1 disruption associates with autism and impaired IGF-1R signaling. [PDF]

open access: yesJ Clin Invest, 2022
Autism spectrum disorder (ASD) represents a group of neurodevelopmental phenotypes with a strong genetic component. An excess of likely gene-disruptive (LGD) mutations in GIGYF1 was implicated in ASD. Here, we report that GIGYF1 is the second-most mutated gene among known ASD high-confidence risk genes.
Chen G   +33 more
europepmc   +4 more sources

R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/Akt axis. [PDF]

open access: yesPLoS ONE, 2011
A subset of patients with Ewing's sarcoma responds to anti-insulin-like growth factor-1 receptor (IGF-1R) antibodies. Mechanisms of sensitivity and resistance are unknown. We investigated whether an anti-IGF-1R antibody acts via a pathway that could also
Helen J Huang   +7 more
doaj   +1 more source

Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment

open access: yesBreast Cancer Research, 2018
Background Early analyses of human breast cancer identified high expression of the insulin-like growth factor type 1 receptor (IGF-1R) correlated with hormone receptor positive breast cancer and associated with a favorable prognosis, whereas low ...
Alison E. Obr   +9 more
doaj   +1 more source

Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patients. [PDF]

open access: yesPLoS ONE, 2015
The insulin-like growth factor 1 receptor (IGF-1R) may be involved in the development of resistance against conventional cancer treatment. The aim of this study was to assess whether IGF-1R expression of breast tumors changes during neoadjuvant therapy ...
Sandra Heskamp   +9 more
doaj   +1 more source

Effective natural inhibitors targeting IGF-1R by computational study

open access: yesAging, 2022
IGF-1R belongs to a tyrosine kinase family and is currently a newly discovered drug target. IGF-1R inhibitors can bind directly to IGF-1R to achieve the effect of inhibiting the function of IGF-1R. At present, IGF-1R inhibitors have good clinical effects on Ewing sarcoma in the clinic. In this article, we screened compounds capable of inhibiting IGF-1R
Wang, Xinyu   +6 more
openaire   +2 more sources

IGF-1R down regulates the sensitivity of hepatocellular carcinoma to sorafenib through the PI3K / akt and RAS / raf / ERK signaling pathways

open access: yesBMC Cancer, 2023
Background Insulin-like growth factor-1 receptor (IGF-1R) promotes cell proliferation and migration and inhibitsapoptosis, all of which can contribute to the development of cancers.
Wenpeng Cai   +6 more
doaj   +1 more source

High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507). [PDF]

open access: yesPLoS ONE, 2009
The IGF receptor type 1 (IGF-1R) pathway is frequently deregulated in human tumors and has become a target of interest for anti-cancer therapy.We used a panel of 22 non-small cell lung cancer (NSCLC) cell lines to investigate predictive biomarkers of ...
Yixuan Gong   +11 more
doaj   +1 more source

IGF-1R Inhibition Activates a YES/SFK Bypass Resistance Pathway: Rational Basis for Co-Targeting IGF-1R and Yes/SFK Kinase in Rhabdomyosarcoma

open access: yesNeoplasia: An International Journal for Oncology Research, 2015
The insulin-like growth factor 1 receptor (IGF-1R) has surfaced as a significant target in multiple solid cancers due to its fundamental roles in pro-survival and anti-apoptotic signaling.
Xiaolin Wan   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy